0001096906-22-002338.txt : 20220923
0001096906-22-002338.hdr.sgml : 20220923
20220923163532
ACCESSION NUMBER: 0001096906-22-002338
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220923
FILED AS OF DATE: 20220923
DATE AS OF CHANGE: 20220923
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: O'Rourke Peter
CENTRAL INDEX KEY: 0001890749
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-54296
FILM NUMBER: 221262723
MAIL ADDRESS:
STREET 1: C/O NORTHVIEW ACQUISITION CORP.
STREET 2: 207 WEST 25TH STREET, 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10001
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AXIM BIOTECHNOLOGIES, INC.
CENTRAL INDEX KEY: 0001514946
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 274092986
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6191 CORNERSTONE COURT, E
STREET 2: SUITE 114
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: (212) 751-0001
MAIL ADDRESS:
STREET 1: 6191 CORNERSTONE COURT, E
STREET 2: SUITE 114
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: AXIM INTERNATIONAL INC.
DATE OF NAME CHANGE: 20110309
3
1
form3.xml
PRIMARY DOCUMENT
X0206
3
2022-09-23
0
0001514946
AXIM BIOTECHNOLOGIES, INC.
AXIM
0001890749
O'Rourke Peter
6191 CORNERSTONE COURT, E.
SUITE 114
SAN DIEGO
CA
92121
1
0
0
0
Option
0.0520
2032-08-22
Common Stock
1000000.0000
D
Reporting Person acquired an option to purchase up to 1,000,000 shares of common stock. 50% of the shares may be purchased immediately and the remaining 50% of the shares may purchased at the date which is six (6) months following the grant date.
/s/ Peter O'Rourke
2022-09-23